Literature DB >> 9869572

Effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in rats and rabbits.

S H Kim1, W B Kim, M G Lee.   

Abstract

The effects of probenecid, an anion transport inhibitor, on the renal excretion mechanism of a new anionic carbapenem, DA-1131, were investigated after a 1-min intravenous infusion of DA-1131 at 100 mg/kg of body weight to rabbits and 50 mg/kg to rats with or without probenecid at 50 mg/kg for both species. In control rabbits, the renal clearance (CLR) of DA-1131 and the glomerular filtration rate based on creatinine clearance (CLCR) were 6.14 +/- 2.09 and 2.26 +/- 0.589 ml/min/kg, respectively. When considering the less than 10% plasma protein binding of DA-1131 in rabbits, renal tubular secretion of DA-1131 was observed in rabbits. The CLR of DA-1131 (3. 87 +/- 0.543 ml/min/kg) decreased significantly with treatment with probenecid in rabbits, indicating that the renal tubular secretion of DA-1131 was inhibited by probenecid. However, in control rats, the CLR of DA-1131 (5.80 +/- 1.94 ml/min/kg) was comparable to the CLCR (4.29 +/- 1.64 ml/min/kg), indicating that DA-1131 was mainly excreted by glomerular filtration in rats. Therefore, it could be expected that the CLR of DA-1131 could not be affected by treatment with probenecid in rats; this was proved by a similar CLR of DA-1131 with treatment with (6.93 +/- 0.675 ml/min/kg) or without (5.80 +/- 1.94 ml/min/kg) probenecid. Therefore, the renal secretion of DA-1131 is a factor in rabbits but is not a factor in rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9869572      PMCID: PMC89027     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Pharmacokinetics and tissue distribution of a new carbapenem DA-1131, after intravenous administration to mice, rats, rabbits and dogs.

Authors:  S H Kim; J W Kwon; M G Lee
Journal:  Biopharm Drug Dispos       Date:  1998-05       Impact factor: 1.627

2.  Determination of a new carbapenem derivative, DA-1131, in plasma and urine by high-performance liquid chromatography.

Authors:  S H Kim; J W Kwon; J Yang; M G Lee
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-01-10

3.  Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure.

Authors:  S H Kim; H J Shim; W B Kim; M G Lee
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 4.  Physiological parameters in laboratory animals and humans.

Authors:  B Davies; T Morris
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

5.  Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem.

Authors:  S H Kim; W B Kim; M G Lee
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1995-12

6.  The pharmacokinetics of meropenem in volunteers.

Authors:  R P Bax; W Bastain; A Featherstone; D M Wilkinson; M Hutchison; S J Haworth
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

Review 7.  An overview of the pharmacology of imipenem/cilastatin.

Authors:  G L Drusano
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

8.  Pharmacokinetics and the effect of probenecid on the renal excretion mechanism of diprophylline.

Authors:  M Nadai; R Apichartpichean; T Hasegawa; T Nabeshima
Journal:  J Pharm Sci       Date:  1992-10       Impact factor: 3.534

9.  Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition.

Authors:  S H Kim; Y M Choi; M G Lee
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

10.  [Mechanism of renal excretion of T-3761, a novel fluoroquinolone agent, in rabbits].

Authors:  Y Fukuda; T Muratani; M Takahata; Y Fukuoka; T Yasuda; Y Watanabe; H Narita
Journal:  Jpn J Antibiot       Date:  1995-05
View more
  3 in total

1.  Effects of cilastatin on the pharmacokinetics of a new carbapenem, DA-1131, in rats, rabbits, and dogs.

Authors:  S H Kim; J W Kwon; W B Kim; M G Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I).

Authors:  Sung Wook Park; Jeoung Soon We; Gye Won Kim; Seong Hak Choi; Haeng Soon Park
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 3.  Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents.

Authors:  H S Sader; A C Gales
Journal:  Drugs       Date:  2001       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.